Table 1 AR-regulated CRPC-Lncs identified in this study.

From: Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors

  

Expression level in the RNA-seq study (Average of RPKM)

No.: ID

Location

Annotation

Benign

Pca

CRPC

#1: NR_039988

chr22:40431590–40431621

n138533

13.7

12.2

31.9

#2: NONHSAT065996

chr19:36815838–36822610

LINC00665

3.0

8.4

21.8

#3: ENST00000444958.1

chr4:53578991–53586518

DANCR

4.6

15.0

30.9

#4: NR_033849

chr8:144816310–144828507

FAM83H-AS1

3.1

11.0

13.2

#5: NR_110115

chr7:100951588–100954619

LOC101927746

0.2

0.4

7.0

#6: ENST00000464464.1

chr7:151574127–151575899

PRKAG2-AS1

3.3

9.6

18.0

#7: ENST00000596366.1

chr10:104210311–104215640

RPARP-AS1

9.7

18.7

27.8

#8: NR_126416

chr6:41491633–41515283

FOXP4-AS1

0.6

2.0

6.3

#9: ENST00000512427.1

chr12:54392806–54393404

HOXC-AS1

0.1

0.0

2.2

#10: NR_132114

chr16:2204783–2205359

SNHG19

16.5

42.4

80.0

#11: NR_120509

chr7:1778266–1781946

ELFN1-AS1

0.0

1.1

8.0

#12: NONHSAT068359

chr19:58823785–58823815

ERVK3-1

111.5

158.9

196.75

  1. RNA-seq RNA-sequencing, RPKM reads per kilobase million, Pca localized prostate cancer, CRPC castration-resistant prostate cancer.
Back to article page